StonvexLoading…
StonvexStonvexStonvexCore line items from NAVN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Annual 2025 2025-01-31 | Q4 2024 2024-10-31 |
|---|---|---|---|---|
Revenue | $702.26M | $524.35M | $536.84M | $404.85M |
Operating Income | $-196.88M | $-107.39M | $-107.64M | $-74.83M |
Net Income | $-398.03M | $-325.27M | $-181.08M | $-134.43M |
EPS (Diluted) | $-4.07 | $-6.94 | $-4.00 | $-2.97 |
Total Assets | $1.71B | $1.79B | $1.08B | Not available |
Total Liabilities | $500.70M | $573.84M | $969.73M | Not available |
Cash & Equivalents | $583.52M | $809.08M | $157.67M | $305.89M |
Free Cash Flow OCF − CapEx | $32.75M | $-1.90M | $-51.40M | $-42.24M |
Shares Outstanding | 97.80M | 46.88M | 45.78M | 45.21M |